Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Pro/Con debate: Maintenance chemotherapy after induction chemotherapy for advanced nonsmall cell lung cancer

Symposium
Chairs: N. Schoenfeld (Berlin, Germany), K. Zarogoulidis (Thessaloniki, Greece)
Aims: Maintenance is a topic of controversy in the first-line management of advanced nonsmall cell lung cancer. Some drugs have obtained a specific registration for that purpose. A lot of questions merit discussion. Wwhat is the exact definition of maintenance (versus consolidation versus early second-line treatment)? What should be the induction chemotherapy? Which drug (cytotoxic agent or tyrosine kinase inhibitor) should be used? How long should be the duration of maintenance? The session will try, by a pro/con debate, to clarify the role of maintenance.

Download all media

PRO: maintenance chemotherapy after induction chemotherapy for advanced nonsmall cell lung cancer T. Brodowicz (Vienna, Austria)
CON: maintenance chemotherapy after induction chemotherapy for advanced nonsmall cell lung cancer B. Grigoriu (Iasi, Romania)